International Treatment as Prevention Workshop

This is an invitational International Workshop dedicated to critically reviewing research related to the secondary preventive benefit (as it relates to HIV and TB transmission) of expanding highly active antiretroviral therapy (HAART) coverage among HIV infected individuals, commonly referred as “Treatment as Prevention” (TasP).

Click here for more on the agenda, webcast, and other information.

International Workshop on Treatment as Prevention

May 4-6, 2011 in Vancouver, Canada

For the agenda, webcast and more information,
click here.

Event hashtag: #TasP


Event Details

Days
Hours
Minutes
Seconds
Start Date
  • May 6, 2011 7:00
End Date
  • May 6, 2011 7:00
Email
education@bccfe.ca
Event Category
  • Conference
Calendar of Events
Click here for the Calendar of Events
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search